The Trillium II Prize


The purpose of this prize is to promote the use by health companies of the FHIR international patient summary (IPS).


International patient summary (IPS) standards consistently adapted and localized to serve the needs of specific use cases are essential to attaining a vision of the patient summary as a social good and human right. Trillium II builds on previous recommendations to put IPS standards at the core of a global community for digital health innovation with the aim of advancing patient safety and trust by bridging the gap between strategic intent and capability to deliver interoperability at a global scale.

Award criteria

The intention is to award the Trillium Prize to the organisation that, in the opinion of the panel of judges, has the best proposal to use, integrate and promote the beneficial use of the FHIR IPS for international medical information exchanges. The specific criteria are:

  • Intended conformance to the specification
  • Ease of interface to EHRs/PHRs (input and output)
  • Numbers and types of patients/persons for whom an IPS is expected to be generated
  • Ease of access by patient while abroad
  • Options for download, redistribution, sharing, directing
  • Expected benefit realisation and anticipated future impact.


The prize will be formally announced at the Connected Health Conference 2018 event in Boston, Mass., USA on 17th October 2018. All the key documents relevant to the IPS that have been finalised to date are available for download on the website at

The competition will close on 15th May 2019. Winners will be announced at an appropriate event in Europe in the month thereafter.


In addition to the promotional benefits from winning the prize, there will be a cash award of €1,000.

Judging panel

The following have been invited to judge the Prize:

Kathi Apostolidis, President – Hellenic Cancer Federation-ELL.O.K.

Elaine Blechman, CEO, Prosocial Applications, Inc. and Professor Emerita, University of Colorado

Christopher Chute, Chief Research Information Officer for Johns Hopkins Medicine

Gora Data, Group Chairman, CAL2CAL Corporation

Marc Lange, Secretary General, European Health Telematics Association (EHTEL), Belgium

Dee O’Sullivan, Director, at PatientView

Mike Short, Chief Scientific Adviser, Department for International Trade, UK

Jeremy Thorp, Director of Business Architecture, NHS UK

Patricia Van Dyke, Vice Chair HL7


Depending on the level of interest in the prize, a subcommittee of Alexander Berler, Catherine Chronaki, Charles Lowe and Janne Rasmussen may select a shortlist of entries for the above to judge. Shortlist selection will be based on the criteria on the previous page.


We are especially keen for SMEs and not-for-profits to apply although any organisation can enter the competition, other than the participants in the Trillium II consortium.

Organisations from all over the world can enter the competition.

Partnerships may enter though only if one organisation in the partnership accepts the lead role.

Registration and application details

All competitors are required to register with MedCom (Lene Taustrup, in order to ensure that they have immediate access to the online registration form and all the updates to the definition of the IPS, and other relevant data that are produced during the competition period, so that they are working from a level playing field. Entries should be in English only. The online form will work to the following format:

  • Applicant details – name, organisation, address including country, other contact details, organisation type, ultimate organisation owner/s.
  • Organisational role – how your organisation proposes to use the IPS to improve international healthcare delivery; who you intend to work with to do this (if any other organisation(s). Max 300 words
  • IPS implementation details – how you plan to deploy the IPS in detail; the type of healthcare service you will be using it in; the specifics of the application. Max 300 words.
  • Coverage – how many people/patients will the IPS reach? What impact is the IPS likely to have on people and on their healthcare system(s)? – please provide justifications for the numbers quoted of people affected, benefit received and improved patient outcomes, including how you verify the results. Max 300 words.
  • The future – extrapolate into the future what benefits your use of the IPS will ultimately deliver – please give a rationale and justification for your projection so the judges can decide how likely it is to happen. Max 300 words

Further information or questions

Please contact

Blog at

Up ↑

%d bloggers like this: